Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD) (IRONPAD)
Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With Lower Extremity Peripheral Artery Disease
Sponsor: Biobizkaia Health Research Institute
Listed as NCT04083755, this PHASE4 trial focuses on Anemia and Peripheral Arterial Occlusive Disease and remains ongoing. Sponsored by Biobizkaia Health Research Institute, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Feb 2023 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Jul 2022 — Feb 2023 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Oct 2021 — Jul 2022 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Recruiting PHASE4
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biobizkaia Health Research Institute
- Sociedad Espanola de Angiologia y Cirugia Vascular
For direct contact, visit the study record on ClinicalTrials.gov .